Organizational Variables in Drug Treatment Efficacy

药物治疗功效的组织变量

基本信息

项目摘要

DESCRIPTION: (provided by applicant) This study advances the understanding of the role of organizational variables in the successful delivery of residential substance abuse treatment protocols. The importance of understanding the organizational features essential to the success of these programs is evident in: (a) the DATOS study finding of great variability in outcomes among residential substance abuse treatment programs, (b) the rapid expansion of residential programs to serve new populations, and (c) changes demanded by third-party funders of these programs. A key organizational variable is internal agreement among clinical director, professional specialty staff, primary treatment staff and clients, about the treatment goals and elements needed for treatment success. According to the formulation, agreement consists of two variables, concordance (Cc: defined as the level of agreement between different groups in an organization, such as administrators, staff, and clients) and consensus (Cs: defined as the level of agreement within these groups). Together, these variables determine the extent of coordinated effort in implementing the treatment protocol. The two variables differ in that high levels of concordance between groups cannot occur without high levels of consensus within the groups, but high levels of consensus can exist without correspondingly high levels of concordance. When Cc is high across all organizational groups, adherence to the prescribed treatment protocol is high. The study investigates a model in which: i) organizational contextual variables (e.g., size of the organization, staff-to-client ratios) affect communication, participation in decision-making and constructive conflict; ii communication, participation in decision-making, and constructive conflict affect Cc and Cs; and iii) Cc and Cs each affect treatment success, measured in terms of staff and client satisfaction, client engagement in treatment, and retention. Aims include 1) determining the relationship between Cc and Cs; 2) identification of the organizational correlates of Cc and Cs; 3) determination the relationship of Cc and Cs with treatment success; and 4) determination of the relationship between client, staff, and program characteristics on the success of residential treatment programs.
描述:(申请人提供) 本研究推进了对组织变量作用的理解 成功实施了住院药物滥用治疗方案。 理解组织特征对组织的重要性, 这些方案的成功是显而易见的:(a)DATOS研究发现, 住院药物滥用治疗方案之间结果的变异性, (b)快速扩展住宅项目,为新人口提供服务, (c)这些项目的第三方资助者所要求的变化。一个关键 组织变量为临床主任内部一致性, 专业的专科人员,基层治疗人员和客户,关于 治疗目标和治疗成功所需的要素。根据 公式,一致性由两个变量组成,一致性(Cc:定义为 一个组织中不同群体之间的一致程度,例如 管理员、员工和客户)和共识(Cs:定义为 在这些团体中)。这些变量共同决定了 在执行治疗方案时协调一致的努力。两个变量 不同之处在于,如果没有高水平的一致性, 集团内部的高度共识,但高度共识可以 没有相应的高度一致性。当Cc高时 在所有组织团体中,坚持规定的治疗 协议很高。该研究探讨了一种模式,其中:i)组织 上下文变量(例如,组织的规模、工作人员与客户的比例) 影响交流、参与决策和建设性的 冲突;二沟通,参与决策,建设性 冲突影响Cc和Cs;以及iii)Cc和Cs各自影响治疗成功, 从工作人员和客户满意度、客户参与度 治疗和保留。目标包括:(1)确定 Cc和Cs; 2)识别Cc和Cs的组织相关性; 3) 确定Cc和Cs与治疗成功的关系;以及4) 确定客户、员工和项目之间的关系 居住治疗方案成功的特点。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The contribution of consensus within staff and client groups as well as concordance between staff and clients to treatment engagement.
工作人员和客户群体内达成共识以及工作人员和客户之间的一致性对治疗参与度的贡献。
  • DOI:
    10.1016/j.jsat.2006.05.002
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Melnick,Gerald;Wexler,HarryK;Chaple,Michael;Banks,Steven
  • 通讯作者:
    Banks,Steven
Racial disparities in substance abuse treatment and the ecological fallacy.
药物滥用治疗的种族差异和生态谬误。
  • DOI:
    10.1080/15332640.2011.600201
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    1.3
  • 作者:
    Melnick,Gerald;Duncan,Alexandra;Thompson,Azure;Wexler,HarryK;Chaple,Michael;Cleland,CharlesM
  • 通讯作者:
    Cleland,CharlesM
Client consensus on beliefs about abstinence: effects on substance abuse treatment outcomes.
客户对禁欲信念的共识:对药物滥用治疗结果的影响。
  • DOI:
    10.1016/j.drugalcdep.2007.08.014
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Melnick,Gerald;Wexler,HarryK;Cleland,CharlesM
  • 通讯作者:
    Cleland,CharlesM
Constructive conflict and staff consensus in substance abuse treatment.
药物滥用治疗方面的建设性冲突和工作人员共识。
  • DOI:
    10.1016/j.jsat.2008.05.002
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Melnick,Gerald;Wexler,HarryK;Chaple,Michael;Cleland,CharlesM
  • 通讯作者:
    Cleland,CharlesM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GERALD Irving MELNICK其他文献

GERALD Irving MELNICK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GERALD Irving MELNICK', 18)}}的其他基金

Organizational Variables in Drug Treatment Efficacy
药物治疗功效的组织变量
  • 批准号:
    6460029
  • 财政年份:
    2002
  • 资助金额:
    $ 41.71万
  • 项目类别:
COMPUTERIZED INSTRUMENT FOR CLIENT TREATMENT MATCHING
用于客户治疗匹配的计算机化仪器
  • 批准号:
    2121860
  • 财政年份:
    1994
  • 资助金额:
    $ 41.71万
  • 项目类别:
TREATMENT READINESS IN SPECIAL POPULATIONS
特殊人群的治疗准备情况
  • 批准号:
    2119873
  • 财政年份:
    1992
  • 资助金额:
    $ 41.71万
  • 项目类别:
TREATMENT READINESS IN SPECIAL POPULATIONS
特殊人群的治疗准备情况
  • 批准号:
    2119874
  • 财政年份:
    1992
  • 资助金额:
    $ 41.71万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.71万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 41.71万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 41.71万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 41.71万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 41.71万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 41.71万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 41.71万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 41.71万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 41.71万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 41.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了